skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Global Generics & Biosimilars Awards 2019

Our expert judges have assessed all the entries for the Global Generics & Biosimilars Awards 2019 to create the shortlist of Award finalists.

We are delighted to announce the shortlist for the 6th annual Global Generics & Biosimilars Awards.

Over the past month, our panel of 17 industry expert judges has reviewed all the entries to produce a shortlist that demonstrates the wealth of innovation, dedication and hard work that the Generics, Biosimilars and Value Added Medicines industries have shown over the past year.

The full range of industry activities is represented: from acquisitions and regulatory achievements, to legal strategies, value added medicines initiatives and CSR breakthroughs. The Global Generics & Biosimilars Awards provides the industry with an opportunity to acknowledge its highest achievers across all parts of the industries, and to recognise both corporate and individual achievements.

Winners of the 14 categories will receive their Awards during a cocktail reception at the Frankfurt Marriott Hotel, Frankfurt, Germany on 5 November. The reception will be hosted by Generics Bulletin with headline sponsor IQVIA. Angela Lamont, British television and conference presenter, will bestow Awards on worthy winners. Attendees will also be able to network with colleagues in the global generics and biosimilars industries.  

Tickets and tables are available on a ‘first come, first served’ basis and space is limited, so make sure you request your complimentary ticket today or book a table to avoid disappointment.  

Congratulations to all our finalists and good luck on the night!


Company of the Year
Accord
Aurobindo
Hikma
Insud Pharma
Sandoz
Stada

Company of the Year, Americas
ANI Pharmaceuticals
Coherus BioSciences
Eurofarma
Lannett

Company of the Year, Asia-Pacific
Aurobindo
Beximco
MSN Laboratories
Piramal Pharma Solutions
Shanghai Henlius Biotech

Company of the Year, EMEA
Accord
Pharmathen
Stada
Zentiva

API Supplier of the Year
Dr Reddy's
mAbxience
MSN Laboratories
Piramal Pharma Solutions
RL Fine Chem


Biosimilar Initiative of the Year
 Accord 
 Pelgraz (pegylated filgrastim)
 Arven Pharmaceuticals  Filgrastim prefilled syringe SC/IV infusion 30 miu/0.5 ml
 mAbxience
 The expansion of bevacizumab worldwide
 Sandoz  Agreement with Gan & Lee to commercialize and supply biosimilars of top three insulins
 Shanghai Henlius Biotech  HLX01 (Rituximab Injection, Recombinant Human/Murine Chimeric Anti-CD20 Monoclonal Antibody Injection)
 Stada
 Expansion of strategic biosimilar development partnership with Xbrane


Acquisition of the Year

 Alvogen                            
 Exeltis product acquisition, including 23 brands
 Aurobindo  Acquisition of dermatology and oral solids businesses from Sandoz
 Eurofarma  Eurofarma reinforces its presence in Chile with the acquisition of Medipharm
 Zentiva  Acquisition of Solacium Pharma (including Be Well Pharma) and Creo Pharma


Leader of the Year

Accord                               
 Binish Chudgar  
Aurobindo  PV Ramprasad Reddy
Hikma  Siggi Olafsson
mAbxience  Emmanuelle Lepine
Stada  Peter Goldschmidt
Zentiva  Nick Haggar

Industry Partner of the Year
Kit Check
Lambda Therapeutic Research
Pharmathen
Piramal Pharma Solutions
Rephine
West Pharma

Value Added Medicine Initiative of the Year

 Accord                             
 Methofill pre-filled syringe and SelfDose injector 
 Intas  Solifenacin orodispersible (fast-disintegrating) tablet
 PharmEvo  Orodispersible powder with micro encapsulated iron
 Stada  Anti-cancer drug bortezomib


Business Development of the Year

Accord                              
 Licensing of leuprorelin depot Injectable for global markets
 Dr Reddy's  Engagement with clients through its no-boundary portal XCEED
 PharmEvo  Orodispersible powder with micro encapsulated iron
 Piramal Pharma Solutions  Patent challenge and launch of treatment for secondary hyperthyroidism
 Stada  Expansion of strategic biosimilar development partnership with Xbrane
 West Pharma   
 The West AccelTRA elastomer components program


Regulatory Achievement of the Year

Alvogen                           
 Oral vinorelbine softgels 
Insud Pharma-Chemo
 Duta Tamsu
Intas  Olmesartan/amlodipine/HCTZ fixed-dose combination
Lupin  Moxonidine tablets and valproate semisodium
Pharmathen  Long acting injectable (LAI) programs.
Sandoz  Generic approval under China’s QCE system


Legal Strategy of the Year

 Accord                           
 Challenge of the bimatoprost 0.01% patent in the UK
 Alvogen  US Revlimid settlement / launch of a Suboxone rival
 Dr Reddy's  Suboxone buprenorphine/naloxone sublingual films
Stada  Launch of anti-cancer drug bortezomib


Corporate Social Responsibility (CSR) Initiative of the Year

Accord                           
 Taking care of our environment, community and people 
 Dr Reddy's  Marking Integrated Transformation for Resourceful Agriculture (MITRA)
 Hikma
 Dedicated to putting high-quality medicines in reach of patients
 Insud Pharma
 Not a single baby with Chagas disease
 Sandoz
 Sandoz HACk – Healthcare Access Challenge
 Teva
 Increasing Access to Medicine

 

Contact us today

For Sponsorship Opportunities contact:

Rob Coulson
Email: rob.coulson@informa.com
Tel: +44 (0) 7900 658185

For all other enquiries:
Natalie Cornwell
Email: natalie.cornwell@informa.com
Tel: +44 (0) 7827 993 776